USPTO serial 79306215
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $325
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 30, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 30, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 12, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 23, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 22, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 9, 2021 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Nov 9, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 24, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 4, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 4, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 4, 2021 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 20, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 17, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 16, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 11, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |